NEW YORK/LEIPZIG, Germany: The US Food and Drug Administration have has given clearance for Genesis, a new implant system developed by Keystone Dental in Burlington, Massachusetts, in the United States. The new system is said to improve the aesthetic outcome of implant procedures through a pink implant collar called AnaTite. It also offers a new nano-surface that mimics the structure of bone and improves osseointegration, the company says.
Keystone offers a variety of dental products including the PRIMA implant which the company acquired from an aquisition of Lifecore Biomedical in 2008. The FDA clearance will give the company the right to market Genesis immediately in the combined North American markets. According to the company, it is expected to be launched in Europe in February 2011.